113 related articles for article (PubMed ID: 32858111)
1. Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704.
Bitterman DS; Winter KA; Hong TS; Fuchs CS; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; Kasunic T; Mulcahy M; Strauss JF; DiPetrillo T; Stella PJ; Chen Y; Plastaras JP; Crane CH
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):201-211. PubMed ID: 32858111
[TBL] [Abstract][Full Text] [Related]
2. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
Reyngold M; Winter KA; Regine WF; Abrams RA; Safran H; Hoffman JP; Mowat RB; Hayes JP; Kessel IL; DiPetrillo T; Narayan S; Chen Y; Ben-Josef E; Delouya G; Suh JH; Meyer J; Haddock MG; Feldman M; Gaur R; Yost K; Peterson RA; Sherr DL; Moughan J; Crane CH
Oncologist; 2020 Mar; 25(3):e477-e483. PubMed ID: 32162826
[TBL] [Abstract][Full Text] [Related]
3. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
Showalter TN; Winter KA; Berger AC; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; MacDonald JS; Willett CG
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1328-35. PubMed ID: 20934270
[TBL] [Abstract][Full Text] [Related]
4. Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
Lu DJ; Luu M; Gay C; Nguyen AT; Anderson EM; Bernier J; Cooper JS; Harari PM; Torres-Saavedra PA; Le QT; Chen MM; Clair JM; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):787-795. PubMed ID: 35395358
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
Wang D; Harris J; Kraybill WG; Eisenberg B; Kirsch DG; Ettinger DS; Kane JM; Barry PN; Naghavi A; Freeman CR; Chen YL; Hitchcock YJ; Bedi M; Salerno KE; Severin D; Godette KD; Larrier NA; Curran WJ; Torres-Saavedra PA; Lucas DR
JAMA Oncol; 2023 May; 9(5):646-655. PubMed ID: 36995690
[TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
Ben-Josef E; George A; Regine WF; Abrams R; Morgan M; Thomas D; Schaefer PL; DiPetrillo TA; Fromm M; Small W; Narayan S; Winter K; Griffith KA; Guha C; Williams TM
Clin Cancer Res; 2015 Dec; 21(24):5612-8. PubMed ID: 26240274
[TBL] [Abstract][Full Text] [Related]
7. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
Ma J; Wang J; Ge L; Long B; Zhang J
Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Stelzl A; Aziz F; Riedl JM; Posch F; Smolle MA; Stojakovic T; Terbuch A; Pichler M; Bergovec M; Leithner A; Liegl-Atzwanger B; Stotz M; Gerger A; Sourij H; Szkandera J
Sci Rep; 2020 Jul; 10(1):12438. PubMed ID: 32709908
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
10. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
Wang NF; Tang HM; Liu FL; Hong QY
Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
12. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
[TBL] [Abstract][Full Text] [Related]
14. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery.
Liu XR; Liu F; Li ZW; Lv Q; Shu XP; Li LS; Tong Y; Zhang W; Peng D
Nutr Cancer; 2023; 75(10):1926-1933. PubMed ID: 37870939
[TBL] [Abstract][Full Text] [Related]
15. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
16. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
17. Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot S; Pijl H; Charehbili A; van de Ven S; Smit VTHBM; Meershoek-Klein Kranenbarg E; Heijns JB; van Warmerdam LJC; Kessels LW; Dercksen MW; Pepels MJAE; van Laarhoven HWM; Vriens BEPJ; Putter H; Fiocco M; Liefers GJ; van der Hoeven JJM; Nortier JWR; Kroep JR;
Breast Cancer Res; 2019 Aug; 21(1):97. PubMed ID: 31455425
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer.
Tseng CM; Wang HH; Wang WL; Lee CT; Tai CM; Tseng CH; Chen CC; Tsai YN; Sun MS; Hsu YC
Endocr Pract; 2020 Jul; 26(7):707-713. PubMed ID: 33471638
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of 272 patients with pancreatic cancer undergoing combined treatment.
Cao N; Zhao A; Zhao G; Wang X; Han B; Lin R; Zhao Y; Yang J
Integr Cancer Ther; 2015 Mar; 14(2):133-9. PubMed ID: 25567328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
